title: Long-term outcome of nephropathic cystinosis: a 20-year single-center experience.
abstract: Nephropathic cystinosis (NC) is a severe disease that is complicated by early-onset chronic renal failure (CRF) and other complications related to cystine deposition in tissue. Since the 1980s, the prognosis of NC has dramatically improved after the introduction of cysteamine treatment. Limited data are available documenting improvement in prognosis. We reviewed our long-term data (follow-up 6.3-27.8 years) on 23 patients followed in the past 26 years. Overall, stage III CRF was reached at 10 years of age in >90% of patients, whereas >80% reached end-stage renal disease before the age of 14 years. Three patients died during the follow-up. Our analysis shows a clear improvement in renal outcome (p = 0.001) and linear growth (p = 0.04) in patients treated more recently. Improvement in the evolution of renal function was significantly associated with early initiation of cysteamine (p = 0.006), with the dose of cysteamine (p = 0.04), and with the use of angiotensin-converting enzyme inhibitors (p = 0.01). Nonrenal long-term complications are similar to previously reported data. Of note, 3/23 patients developed rare forms of primary tumors that were successfully treated. In conclusion, our experience shows a significant improvement in the renal and nonrenal complications of cystinosis over the past decades and highlights the importance of early diagnosis in order to initiate cysteamine as soon as possible.
authors.affiliation: Department of Nephrology and Urology, Bambino Gesù Children's Hospital and Research Institute, Rome, Italy. greco@opbg.net
authors.forename: Marcella
authors.initials: M
authors.lastname: Greco
authors.forename: Milena
authors.initials: M
authors.lastname: Brugnara
authors.forename: Marco
authors.initials: M
authors.lastname: Zaffanello
authors.forename: Anna
authors.initials: A
authors.lastname: Taranta
authors.forename: Anna
authors.initials: A
authors.lastname: Pastore
authors.forename: Francesco
authors.initials: F
authors.lastname: Emma
mesh_terms: D000293:Adolescent; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003543:Cysteamine / Q000627:therapeutic use*; D003554:Cystinosis; D018450:Disease Progression; D004359:Drug Therapy, Combination; D042241:Early Diagnosis; D005198:Fanconi Syndrome; D005260:Female; D006801:Humans; D007223:Infant; D007558:Italy; D053208:Kaplan-Meier Estimate; D007668:Kidney / Q000187:drug effects* / Q000503:physiopathology; D007676:Kidney Failure, Chronic / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D016015:Logistic Models; D008297:Male; D009404:Nephrotic Syndrome / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology; D012189:Retrospective Studies; D018570:Risk Assessment; D012307:Risk Factors; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D003543:Cysteamine
references.citation: Pediatr Nephrol. 2008 Jun;23(6):863-78
references.pmid: 18008091
references.citation: Mol Cell Biol. 2002 Nov;22(21):7622-32
references.pmid: 12370309
references.citation: Arch Dis Child. 1982 Dec;57(12):934-9
references.pmid: 7181523
references.citation: Nephrol Dial Transplant. 2002 Nov;17(11):1883-6
references.pmid: 12401840
references.citation: Pediatr Nephrol. 1994 Aug;8(4):466-71
references.pmid: 7947039
references.citation: Pediatr Nephrol. 2008 Feb;23(2):307-10
references.pmid: 17638022
references.citation: J Biol Chem. 1985 Apr 25;260(8):4791-8
references.pmid: 3921538
references.citation: Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008 Dec;106(6):866-71
references.pmid: 18926732
references.citation: Pediatr Transplant. 2011 May;15(3):e56-9
references.pmid: 20070558
references.citation: JAMA. 1993 Nov 10;270(18):2200-4
references.pmid: 8411603
references.citation: Clin Nephrol. 2003 Dec;60(6):386-9
references.pmid: 14690254
references.citation: J Clin Endocrinol Metab. 1995 Nov;80(11):3257-61
references.pmid: 7593434
references.citation: J Pediatr. 2004 Oct;145(4):555-60
references.pmid: 15480385
references.citation: Pediatr Nephrol. 2008 Jul;23(7):1167-70
references.pmid: 18286306
references.citation: N Engl J Med. 2007 Aug 23;357(8):797-805
references.pmid: 17715412
references.citation: N Engl J Med. 1987 Apr 16;316(16):971-7
references.pmid: 3550461
references.citation: Fertil Steril. 2010 Apr;93(6):1880-3
references.pmid: 19217094
references.citation: Clin Chem. 2004 Sep;50(9):1686-8
references.pmid: 15331510
references.citation: Kidney Int. 2001 Nov;60(5):1885-92
references.pmid: 11703607
references.citation: Pediatr Nephrol. 2006 Jan;21(1):110-3
references.pmid: 16252107
references.citation: Pediatrics. 1976 Aug;58(2):259-63
references.pmid: 951142
references.citation: N Engl J Med. 2002 Jul 11;347(2):111-21
references.pmid: 12110740
references.citation: Ann Intern Med. 2007 Aug 21;147(4):242-50
references.pmid: 17709758
references.citation: N Engl J Med. 2009 Oct 22;361(17):1639-50
references.pmid: 19846849
references.citation: Nat Genet. 1998 Apr;18(4):319-24
references.pmid: 9537412
references.citation: J Inherit Metab Dis. 1995;18(4):387-97
references.pmid: 7494398
references.citation: Eur J Hum Genet. 2003 Jul;11(7):503-8
references.pmid: 12825071
references.citation: Clin Chem. 2000 Apr;46(4):574-6
references.pmid: 10760232
references.citation: Am J Kidney Dis. 2008 Jun;51(6):893-903
references.pmid: 18455850
references.citation: Nephrol Dial Transplant. 2002 Oct;17(10):1766-70
references.pmid: 12270982
references.citation: Oral Dis. 2010 Jul;16(5):488-95
references.pmid: 20233313
references.citation: N Engl J Med. 1993 Apr 22;328(16):1157-62
references.pmid: 8455682
references.citation: Pediatr Nephrol. 1999 Aug;13(6):524-9
references.pmid: 10452283
references.citation: Arch Dis Child. 1976 Mar;51(3):170-9
references.pmid: 952550
references.citation: Eur J Pediatr. 2003 Dec;162 Suppl 1:S38-41
references.pmid: 14610675